Clinical Trials Logo

Clinical Trial Summary

Evaluation of the SpinCare™ System in the Treatment of Partial Thickness Burns. A prospective, single arm, safety and efficacy, open labeled multi-center study

Clinical Trial Description

The SpinCare is an electrospinning portable device intended for the external treatment of burns and wounds. The SpinCare is the first made on the spot, bed side, and completely personalized dressing system; with excellent coverage of all size, shapes and difficult contours. The nano-fibrous dressing mimics the structure of natural body tissue and creates excellent medium for tissue repair and healing.

The objective of this study is to evaluate the performance, safety and efficacy of the SpinCare System in the treatment of superficial to intermediate partial thickness burns.

The study will include up to 6 sites. Adult patients with superficial to intermediate partial thickness burns (second degree superficial to intermediate) of up to 10% TBSA (Total Body Surface Area); with an independent burn of up to 5% TBSA.

A prospective single arm, safety and efficacy, open labeled, multi-center study for the treatment of partial thickness burn wounds not considered for surgery using the SpinCare System.

20 patients will be enrolled in the study.

Primary endpoints:

- Wound healing and re-epithelialization on day 21.

- The burn will be considered healed when at least 95% of the total area is re-epithelialized and no scabs exist.

- Ease of use

- At postoperative days 7, 14, 21

- Dermal safety assessed by Draize Score

- Visual estimate of wound healing and re-epithelialization

- Pain

- Infection

- Itching

- Itching and scar quality at 3 and 6 months

- Itching and scar quality at 12 months (optional)

- Device related adverse events ;

Study Design

Related Conditions & MeSH terms

NCT number NCT02997592
Study type Interventional
Source Nicast Ltd.
Contact Amnon Gildor, MD
Phone +972-8-9153001
Email [email protected]
Status Recruiting
Phase N/A
Start date March 26, 2017
Completion date March 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT01455480 - Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn Phase 1/Phase 2